February 15, 2022
Advancing a new era of regenerative medicine
Allegorically speaking, if Mayo Clinic were a garden and regenerative technologies were fruits and vegetables, William Faubion Jr., M.D., sees himself as a gardener tending to the teams responsible for these new healing therapies. Dr. Faubion, who is the newly named associate medical director for Mayo Clinic’s Center for Regenerative Medicine, wants to advance discoveries […]
Tags: Allan Dietz, biomedical engineering, CAR-T cell therapy, Center for Regenerative Medicine, Crohn's disease, Eric Dozois, gastroenterology, immune system, inflammatory bowel disease, perianal fistula, regenerative medicine research, surgery
August 23, 2021
Mayo Clinic Research in the news — 8/23/2021
By Advancing the Science contributor
In the last 15 days or so, COVID-19 related news continues to dominate the headlines on the research front. However, Mayo Clinic’s expertise also was evident on topics from inclusivity in clinical trials, a geological connection in kidney stones, life extending therapies and better understanding of contributors to dementia, stroke and death. Read on for […]
Tags: brain, clinical trials, cognitive impairment, COVID-19, dementia, diversity, health disparities, hypertension, idiopathic pulmonary fibrosis, immune system, kidney stones, knee replacement
May 14, 2021
Mayo Clinic Proceedings: In the Limelight, May 2021
By Advancing the Science contributor
Mayo Clinic publishes two peer-reviewed journals, accepting original research and related content from investigators around the world. Advancing the Science shares stories about research published in Mayo Clinic Proceedings, its sister journal, and many other English-language journals. In order to gain more visibility for all the research covered by Mayo’s premier journal, we are going to reprint ‘In […]
Tags: AFib, Andrew Tseng, antibodies, atrial fibrillation, cardiology, COVID-19, epidemiology, FDA, immune system, Karl Nath, Mayo Clinic Proceedings, multiple chronic conditions
April 1, 2021
Research News Roundup — Q1 2021
The first quarter of 2021 saw furthered understanding the SARS-CoV-2 virus and related COVID-19 viral infection. In addition, a number of advances occurred including in genetics knowledge, cancer treatments, as well as interinstitutional collaborations, expanding programs and recognition of some of the most exceptional contributions of current and former Mayo Clinic clinician-scientists. Mayo Clinic and ASU […]
Tags: Arizona State University, biomarkers, brain cancer, BRCA2, breast cancer, chemotherapy, COVID-19, David Holmes Jr., diversity, education, Fergus Couch, gene variant
November 10, 2020
Advancing neuroscience at Mayo Clinic in Florida: Dr. Sandro Da Mesquita
By Advancing the Science contributor
What is your background? I am a biochemist by training and performed all of my graduate studies in Portugal, at the School of Medicine of the University of Minho, located in a northern Portuguese city called Braga. It was in grad school that I started to develop a particular taste for neuroscience and cellular and […]
Tags: ALS, Alzheimer's disease, amyotrophic lateral sclerosis, brain, cognitive impairment, dementia, immune system, lymphatic system, neuroimmunology, neurosciences, research education, Sandro Da Mequita
October 2, 2020
Mayo Clinic Research in the news — 10/2/2020
This week Mayo Clinic Research and researchers have been noted in stories on older women’s sexuality, the opioid crisis, some health benefits of coffee, using Alexa for COVID-19, and a range of other topics. Read on for links and brief excerpts from news outlets around the country. Laughter May Be Effective Medicine for These Trying […]
Tags: Amir Lerman, artificial intelligence, B-cell disorders, biomarkers, C. diff, cancer, cardiology, colon cancer, COVID-19, diabetes, dogs, emergency medicine
April 27, 2020
Mayo Clinic Research in the news: Week in review 4/27/2020
Last week, much like the previous, was full of news related to COVID-19. Mayo Clinic Research and researchers played a prominent role in the discussion. Collected here are links and snippets from some of the stories from around the world. They connect Mayo Clinic research and international efforts to understand and reduce the devastating effects […]
Tags: Andrew Badley, antibodies, artificial intelligence, clinical trials, COVID-19, Dawn Davis, Department of Laboratory Medicine and Pathology, dermatology, Elitza Theel, Gregory Poland, immune system, Laura Breeher
April 20, 2020
Mayo Clinic Research in the news: Week in review 4/20/2020
Many of us have passed another week of “stay at home” but others are on the front lines of patient care and COVID-19 research. How does it spread? Why do some people contract more serious cases, or develop more antibodies? How many people have been exposed? These are just a few of the questions Mayo […]
Tags: Andrew Badley, antibodies, basic science, biomedical research, cardiology, Colin West, COVID-19, Department of Laboratory Medicine and Pathology, Elitza Theel, Gregory Poland, immune system, immunity
April 13, 2020
Mayo Clinic Research in the news: Week in review 4/13/2020
Another week, another set of stories. Very little hit the newstands in health care that wasn’t COVID-19. However, you may rest assured, research continues into a wide range of health conditions, rare diseases and ways to improve health and health care. We’ve included an excerpt and link to several of the news stories published in […]
Tags: Ala S. Dababneh, antibodies, blood test, cardiology, clinical trials, COVID-19, Elitza Theel, epidemiology, Gregory Poland, ICU, immune system, Mayo Clinic Health System
April 6, 2020
Mayo Clinic Research in the News — Week in Review 4/6/2020
In the last week, as you might imagine, most of the news being covered by the media is about COVID-19. We’ve included an excerpt and link to several of these stories discussing Mayo Clinic Research. We found a couple items covering other things we are working on, so included them first, for your awareness. Study: […]
Tags: blood test, cancer, cancer screening, cardiology, clinical trials, COVID-19, FDA, Gregory Poland, Henry Ting, immune system, Mayo Clinic Laboratories, Michael Ackerman